Lymphangiosarcoma+34
RecruitingStudy of Trabectedin alone versus Trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment
Study of Trabectedin alone versus Trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment
- Disease:LymphangiosarcomaLiposarcoma+33
- Substances:Ttf-Ngr
Germany- Participants:18–64 years · 65+ years
- Substances:Ttf-Ngr
- Sponsor:Universitaet Muenster








